| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.04 |